Orthocell Gains Approval for Collagen Scaffold Study

Orthocell was granted ethical approval by St Vincent’s Hospital Melbourne, Australia, for a clinical study using the Celgro SMRT Graft collagen scaffold.

Launching in 2Q16, the 25-patient study will investigate safety and tolerability of Celgro as a collagen matrix treatment for osteochondral defects in the hip—specifically, an enhanced...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us